Management of paediatric glioblastoma

Area of Science:

• Pediatric oncology
• Neuro-oncology
• Clinical research

Background:

• Glioblastoma is a rare pediatric brain tumor, comprising less than 5% of childhood brain tumors.
• Established treatments like surgery, chemotherapy, and radiotherapy significantly influence survival rates in large cohorts.
• Disparities in applying these standard treatments exist in real-world settings, particularly in low- and middle-income countries (LMICs).

Purpose of the Study:

• To review and synthesize key findings from studies focusing on pediatric glioblastoma.
• To highlight critical aspects of pediatric glioblastoma management and outcomes.
• To underscore the importance of evidence-based practices in diverse healthcare settings.

Main Methods:

• Systematic literature review of studies on pediatric glioblastoma.
• Analysis of treatment modalities including extent of resection, chemotherapy, and radiotherapy.
• Evaluation of survival data and real-world treatment application.

Main Results:

• Evidence confirms that the extent of surgical resection is a critical factor for survival in pediatric glioblastoma.
• Adjuvant chemotherapy and radiotherapy play a significant role in improving outcomes.
• Implementation of optimal treatment strategies may be inconsistent in real-world clinical practice, especially in LMICs.

Conclusions:

• Optimizing surgical resection and adjuvant therapies are crucial for improving pediatric glioblastoma survival.
• Addressing the challenges in real-world treatment delivery is essential for equitable patient care.
• Further research and improved healthcare infrastructure are needed in LMICs to enhance outcomes for children with glioblastoma.